Inovio Pharmaceuticals, Inc.

INO

$1.36

+0.00%

2026-09-03 16:00:01 EDT+$0.00

Healthcare

Biotechnology

NASDAQ

Active Trading

Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is ...

C-Suite Executives

(0)

The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.

Key Team Members

No executives available for this level

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Gender	Year Born	Status
Jacqueline E. Shea	Chief Executive Officer, President & Director	USD 889,099	—	1966	Active
Laurent Humeau	Chief Scientific Officer & Chairman of the Scientific Advisory Board	USD 794,082	—	1967	Active
Michael Sumner	Chief Medical Officer & Head of Development	USD 653,475	—	1965	Active
Peter D. Kies	Chief Financial Officer	USD 598,278		1963	Active
Robert L. Crotty	General Counsel, Corporate Secretary & Chief Compliance Officer	—		1974	Active
E. J. Brandreth	Senior Vice President of Quality Assurance	—		—	Active
Robert J. Juba Jr.	Senior Vice President of Biological Manufacturing & Clinical Supply Management	—		—	Active
Jeffrey Skolnik	Senior Vice President of Clinical Development	—	—	—	Active
Shawn D. Bridy	Senior Vice President of Business Development	—		—	Active
Jennie Willson	Director of Communications	—		—	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total
2026-04-07	2025	Jacqueline E. Shea, Ph.D.	President President and Chief Chief Executive Officer	Founder / CEO	$728.00K	$0	$346.10K	$351.95K	$144.14K	$16.95K	$1.59M
2026-04-07	2025	Michael Sumner, M.D.	Chief Chief Medical Officer and Head of Development	C-Level	$548.71K	$0	$127.61K	$129.55K	$87.39K	$17.38K	$910.64K
2026-04-07	2025	Peter D. Kies	Chief Chief Financial Officer	C-Level	$514.60K	$0	$117.48K	$117.93K	$68.24K	$15.44K	$833.68K
2026-04-07	2024	Jacqueline E. Shea, Ph.D.	President President and Chief Chief Executive Officer	Founder / CEO	$728.00K	$0	$490.82K	$475.98K	$340.70K	$15.17K	$2.05M
2026-04-07	2024	Michael Sumner, M.D.	Chief Chief Medical Officer and Head of Development	C-Level	$532.00K	$47.13K	$139.60K	$136.32K	$167.11K	$15.25K	$1.04M
2026-04-07	2024	Peter D. Kies	Chief Chief Financial Officer	C-Level	$506.81K	$0	$131.96K	$127.98K	$158.12K	$15.20K	$940.07K

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

Supply Chain of INO

RELATIONS

Upstream

Richter BioLogics (formerly Richter-Helm BioLogics)BUX:GDRBThermo Fisher Scientific (Patheon CDMO)NYSE:TMOKaneka EurogentecTSE:4118Resilience (National Resilience, Inc.)Inovio Device Engineering & Manufacturing Facility (San Diego, CA)Gedeon Richter PlcBUX:GDRBKaneka CorporationTSE:4118

Downstream

ApolloBio CorporationNEEQ:430187Akeso, Inc.HKEx:9926 Coherus Oncology (formerly Coherus BioSciences)NASDAQ:CHRS AstraZeneca (MedImmune)NASDAQ:AZNSpecialty Distributor (Not Yet Named Publicly)Third-Party Logistics Provider (Not Yet Named Publicly)

Proxies

Moderna, Inc.NASDAQ:MRNA BioNTech SENASDAQ:BNTX AstraZeneca PLCNASDAQ:AZN Thermo Fisher Scientific Inc.NYSE:TMO

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer